Diclofenac increases beta-endorphin plasma concentrations

J Int Med Res. 1984;12(2):92-5. doi: 10.1177/030006058401200205.

Abstract

Plasma and ventricular cerebro-spinal fluid (CSF) Beta-endorphin concentrations were evaluated after chromatographic separation in patients carrying a ventricular shunt before and after the administration of diclofenac or placebo. In the same subjects the ventricular CSF concentrations of the serotonin and the catecholamine metabolites 5-hydroxyindole-acetic acid (5-HIAA), homovanillic acid (HVA) and MOPEG were also evaluated. Plasma, but not ventricular, Beta-endorphin concentrations increased significantly after diclofenac, while placebo was ineffective. No significant changes in ventricular 5-HIAA, HVA or MOPEG levels were observed. These data suggest a role for Beta-endorphin in the analgesic effect of diclofenac.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Cerebrospinal Fluid Shunts
  • Diclofenac / pharmacology*
  • Endorphins / blood*
  • Endorphins / cerebrospinal fluid
  • Female
  • Heart Atria
  • Homovanillic Acid / cerebrospinal fluid
  • Humans
  • Hydroxyindoleacetic Acid / cerebrospinal fluid
  • Male
  • Methoxyhydroxyphenylglycol / cerebrospinal fluid
  • Middle Aged
  • Peritoneal Cavity
  • Phenylacetates / pharmacology*
  • Radioimmunoassay
  • Stimulation, Chemical
  • beta-Endorphin

Substances

  • Endorphins
  • Phenylacetates
  • Diclofenac
  • Methoxyhydroxyphenylglycol
  • Hydroxyindoleacetic Acid
  • beta-Endorphin
  • Homovanillic Acid